Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs

被引：0

作者：

Aisanov, ZR ^{[1
]}

Kalmanova, EN

Chuchalin, AG

机构：

[1] Pulmonol Sci Res Inst, Minist Hlth, Moscow, Russia

[2] Res Ctr Russian Fed, Moscow, Russia

来源：

TERAPEVTICHESKII ARKHIV | 2004年 / 76卷 / 12期

关键词：

lecture; chronic obstructive pulmonary disease; cardiovascular diseases; combination; treatment; cholinolytics;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：81 / 82

页数：2

共 50 条

[21] Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
Sata, Makoto
CIRCULATION JOURNAL, 2010, 74 (02) : 254 - 255
[22] Cardiovascular Disease and Cardiovascular Drugs in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Survival Analysis.
Sarc, I.
Jeric, T.
Ziherl, K.
Kosnik, M.
Suskovic, S.
Anker, S. D.
Lainscak, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[23] Chronic Obstructive Pulmonary Disease: Breathing New Life into Old Cardiovascular Drugs?
Polverino, Francesca
Celli, Bartolome R.
Owen, Caroline A.
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (11) : 1718 - 1718
[24] PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN OUTPATIENTS WITH CARDIOVASCULAR DISEASES IN JAPAN
Onishi, Katsuya
Yoshimoto, Daisuke
Hagan, Gerry
Jones, Paul W.
RESPIROLOGY, 2013, 18 : 183 - 183
[25] Clinico-Pathogenetic Relationship of Cardiovascular Diseases and Chronic Obstructive Pulmonary Disease
Budnevsky, A. V.
Malysh, E. Y.
KARDIOLOGIYA, 2017, 57 (04) : 89 - +
[26] Characteristics and Outcomes of People with Cardiovascular Diseases with and Without Chronic Obstructive Pulmonary Disease
Cho, E. E.
Maclagan, L. C.
Croxford, R.
Chu, A.
Sin, D. D.
Udell, J.
Lee, D.
Gershon, A. S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[27] Comorbidity, chronic obstructive pulmonary disease, and acute cardiovascular diseases The Greek experience
Papastergiou, K.
Gourgoulianis, K.
HERZ, 2018, 43 (05) : 466 - 468
[28] Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
Sin, DD
Man, SFP
CIRCULATION, 2003, 107 (11) : 1514 - 1519
[29] The Place of β-adrenoblockers in the Treatment of Cardiovascular Disease in Patients With Chronic Obstructive Pulmonary Disease
Statsenko, M. E.
Derevyanchenko, M. V.
KARDIOLOGIYA, 2012, 52 (12) : 57 - 63
[30] New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease
Brassington, Kurt
Selemidis, Stavros
Bozinovski, Steven
Vlahos, Ross
CLINICAL SCIENCE, 2019, 133 (07) : 885 - 904

← 1 2 3 4 5 →